venerdì 25 aprile 2014

Johnson & Johnson Profit Jumps As Prescription Drug Sales Surge And Outlook Increases

Johnson & Johnson easily beat the Street with its first quarter earnings results Tuesday morning, reporting a 3.5% lift in revenue and a near-8% jump in profit thanks to strong sales in its prescription drug segment.



Johnson & Johnson Profit Jumps As Prescription Drug Sales Surge And Outlook Increases

#JohnsonJohnson, #JohnsonJohnsonProfitJumps, #PrescriptionDrugSalesSurge

Nessun commento:

Posta un commento